The University of Oxford has launched a trial to study the safety and efficacy of the AstraZeneca COVID-19 vaccine in children under 6 years of age. The University of Oxford said the study would involve 300 volunteers, of whom 240 would receive the vaccine while 60 others would receive a meningitis shot.

The university said the 60 men who get meningitis shots will serve as controls, and that the jab is safe in children but is also expected to cause similar reactions.

The researchers are aiming to enroll 300 volunteers in the latest trial.

The researchers are aiming to enroll 300 volunteers in the latest trial.

The trial, which aims to study the AstraZeneca vaccine in children and adolescents between the ages of 6 and 17, will build on previous data that have shown to be safe and effective when used on adults. Pfizer recently announced that a trial involving children under 12 years of age reached full enrollment, and Modern plans a trial for children aged 12–17.

If an employee works during COVID-19 vacancy, he will be found

“While most children are relatively unaffected by coronaviruses and are unlikely to be unwell with infection, it is important to establish a safety and immune response to the vaccine in children and young people as some children may benefit from vaccination,” Andrew Murd, Professor Bal Medical Infection and Immunity, and Chief Investigator of Oxford University Trials A news release stated.

None of the coronovirus vaccines approved for use in children were cured. In the US, Pfizer and BioNotech vaccines received emergency use authorization for children under 16, but the second, Modern, receiving such authorization was approved only for those older than 18 .

In america, The American Academy of Pediatrics recently called All people 16 and older, who meet the criteria for priority vaccination to get one, and renewed their push for more tests from children and teens.

Click here for complete coronary coverage

The President of AAP, Dr. “It is important that pediatric patients of all ages be included in the trial as soon as possible,” said Lee Savio Brier. “We are particularly concerned about children who belong to racial, ethnic and cultural groups who have been severely affected by the epidemic or who have underlying conditions that put them at increased risk for developing severe COVID-19 infections Keep. “

up 2.9 million children in America COVID-19 has been diagnosed since the onset of the epidemic, although the number of pediatric cases diagnosed worldwide is unclear.